Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation have?
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation has 377 citations in the OpenAlex counts ScholarIQ stores.
When was Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation published?
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation has 1995 year in the ScholarIQ index.
What is the open-access status of Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation?
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation has hybrid oa status in the ScholarIQ index.
What is the DOI of Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation?
The DOI for Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation is on the source record.
What is the PMID of Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation?
The PMID for Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation is on the source record.
What is the OpenAlex record for Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation?
The OpenAlex for Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation is on the source record.